Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1993 Jun;69(6):481–482. doi: 10.1136/hrt.69.6.481

Radiation induced coronary heart disease.

D Sebag-Montefiore, H Hope-Stone
PMCID: PMC1025155  PMID: 8343311

Full text

PDF
481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boivin J. F., Hutchison G. B. Coronary heart disease mortality after irradiation for Hodgkin's disease. Cancer. 1982 Jun 15;49(12):2470–2475. doi: 10.1002/1097-0142(19820615)49:12<2470::aid-cncr2820491210>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  2. Bradley E. W., Zook B. C., Casarett G. W., Rogers C. C. Coronary arteriosclerosis and atherosclerosis in fast neutron or photon irradiated dogs. Int J Radiat Oncol Biol Phys. 1981 Aug;7(8):1103–1108. doi: 10.1016/0360-3016(81)90169-3. [DOI] [PubMed] [Google Scholar]
  3. CATTERALL M., EVANS W. Myocardial injury from therapeutic irradiation. Br Heart J. 1960 Apr;22:168–174. doi: 10.1136/hrt.22.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carmel R. J., Kaplan H. S. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer. 1976 Jun;37(6):2813–2825. doi: 10.1002/1097-0142(197606)37:6<2813::aid-cncr2820370637>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  5. Cohn K. E., Stewart J. R., Fajardo L. F., Hancock E. W. Heart disease following radiation. Medicine (Baltimore) 1967 May;46(3):281–298. doi: 10.1097/00005792-196705000-00003. [DOI] [PubMed] [Google Scholar]
  6. Cosset J. M., Henry-Amar M., Meerwaldt J. H. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group. Ann Oncol. 1991 Feb;2 (Suppl 2):77–82. doi: 10.1093/annonc/2.suppl_2.77. [DOI] [PubMed] [Google Scholar]
  7. Cuzick J., Stewart H., Peto R., Baum M., Fisher B., Host H., Lythgoe J. P., Ribeiro G., Scheurlen H., Wallgren A. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 1987 Jan;71(1):15–29. [PubMed] [Google Scholar]
  8. Hancock S. L., Hoppe R. T., Horning S. J., Rosenberg S. A. Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. Ann Intern Med. 1988 Aug 1;109(3):183–189. doi: 10.7326/0003-4819-109-3-183. [DOI] [PubMed] [Google Scholar]
  9. Haybittle J. L., Brinkley D., Houghton J., A'Hern R. P., Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ. 1989 Jun 17;298(6688):1611–1614. doi: 10.1136/bmj.298.6688.1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Høst H., Brennhovd I. O., Loeb M. Postoperative radiotherapy in breast cancer--long-term results from the Oslo study. Int J Radiat Oncol Biol Phys. 1986 May;12(5):727–732. doi: 10.1016/0360-3016(86)90029-5. [DOI] [PubMed] [Google Scholar]
  11. Jones J. M., Ribeiro G. G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 1989 Mar;40(2):204–208. doi: 10.1016/s0009-9260(89)80099-6. [DOI] [PubMed] [Google Scholar]
  12. Sebag-Montefiore D. J., Maher E. J., Young J., Hudson G. V., Hanks G. Variation in mantle technique: implications for establishing priorities for quality assurance in clinical trials. Radiother Oncol. 1992 Mar;23(3):144–149. doi: 10.1016/0167-8140(92)90324-n. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES